ExSight Ventures

ExSight Ventures is a life sciences venture capital firm investing in early-stage ophthalmic innovation, spanning biotechnology, medical devices, pharmaceuticals and healthcare software. Its stated philosophy is returns-oriented and mission-focused, and the firm positions itself as a specialist investor in ophthalmology rather than a generalist healthcare fund. It was founded in part to address a shortage of early-stage funding available to life science companies.

Investments are made from pre-seed through Series B stages. The firm emphasises capital-efficient development in its portfolio companies and applies a focused ophthalmology expertise to the evaluation of emerging technologies and to guiding companies through their formative stages. Beyond capital, it provides domain insight, advice and access to relationships with innovators, scientists, academics and strategic partners.

The investment team includes retinal surgeons with clinical ophthalmology experience, combining clinical and investment perspectives in the identification of opportunities. Technical domains of interest include ophthalmology, retinal surgery, biotechnology, medical devices, pharmaceuticals, healthcare software, venture capital and asset management.